Nesting a Target Study within a Target Trial: A Framework for Evaluating Intervention Effects on Disparities

Read full text
Authors: Xinying Sun, Theodore John Iwashyna, Emmanuel Fulgence Drabo, Deidra C. Crews, Kadija Ferryman, John Wyse Jackson
Cited by: 0
References: 54

Abstract

We present a novel framework (TS+TT) to nest a target study (TS) within a target trial (TT) for evaluating the effects of interventions on disparities. The target study component grounds the measurement of disparity in ethical assumptions, based on the concept of allowability, and anchors it to an explicit population within calendar time. It specifies an enrollment plan of stratified sampling of eligible persons to yield a sample where social groups are distributionally similar on covariates deemed allowable for measuring disparity. Within this enrolled sample, the target trial component specifies randomization of intervention strategies within each social group. Because social groups are similarly situated on allowable covariates at baseline, and because assigned intervention arms are exchangeable within social groups, TS+TT reflects a meaningful causal estimand for evaluating how interventions impact disparity. We describe the framework's key components, its emulation, and demonstrate its application to evaluate how hypothetical interventions on pulse oximeter bias affect disparities in treatment receipt in clinical care. We also extend semiparametric G-computation to accommodate continuous stochastic interventions and estimate counterfactual disparities in time-to-event outcomes. The TS+TT framework offers a versatile and policy-relevant approach for generating ethically informed causal evidence to reduce disparities and avoid exacerbating disparities.

Fields of Study & Subjects

Dietetics Nutrition and Education Pharmaceutical Practices and Patient Outcomes Global Health Workforce Issues

Publication details

Journal / source
Epidemiology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
37
Issue
6
Pages
727-737
Publication date
21 July 2026
Language
EN